Citadel Advisors’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $331K | Buy |
+249,025
| New | +$331K | ﹤0.01% | 4506 |
|
|
2025
Q1 | – | Sell |
-220,215
| Closed | -$359K | – | 6684 |
|
|
2024
Q4 | $359K | Buy |
220,215
+105,233
| +92% | +$172K | ﹤0.01% | 4343 |
|
|
2024
Q3 | $439K | Buy |
114,982
+66,272
| +136% | +$253K | ﹤0.01% | 3922 |
|
|
2024
Q2 | $143K | Sell |
48,710
-2,655
| -5% | -$7.78K | ﹤0.01% | 4800 |
|
|
2024
Q1 | $203K | Sell |
51,365
-79,017
| -61% | -$313K | ﹤0.01% | 4777 |
|
|
2023
Q4 | $648K | Buy |
130,382
+34,393
| +36% | +$171K | ﹤0.01% | 3466 |
|
|
2023
Q3 | $485K | Buy |
95,989
+45,138
| +89% | +$228K | ﹤0.01% | 3781 |
|
|
2023
Q2 | $256K | Sell |
50,851
-74,056
| -59% | -$373K | ﹤0.01% | 4239 |
|
|
2023
Q1 | $768K | Buy |
124,907
+97,679
| +359% | +$601K | ﹤0.01% | 3447 |
|
|
2022
Q4 | $359K | Sell |
27,228
-91,795
| -77% | -$1.21M | ﹤0.01% | 4173 |
|
|
2022
Q3 | $353K | Buy |
119,023
+87,106
| +273% | +$258K | ﹤0.01% | 4398 |
|
|
2022
Q2 | $116K | Sell |
31,917
-55,461
| -63% | -$202K | ﹤0.01% | 5230 |
|
|
2022
Q1 | $541K | Sell |
87,378
-32,704
| -27% | -$202K | ﹤0.01% | 4364 |
|
|
2021
Q4 | $973K | Sell |
120,082
-98,965
| -45% | -$802K | ﹤0.01% | 3879 |
|
|
2021
Q3 | $3.26M | Buy |
219,047
+130,633
| +148% | +$1.95M | ﹤0.01% | 2468 |
|
|
2021
Q2 | $1.11M | Buy |
+88,414
| New | +$1.11M | ﹤0.01% | 3890 |
|
|
2019
Q1 | – | Sell |
-3,020
| Closed | -$19K | – | 4894 |
|
|
2018
Q4 | $19K | Buy |
+3,020
| New | +$19K | ﹤0.01% | 4289 |
|
|
2018
Q2 | – | Sell |
-2,862
| Closed | -$68K | – | 4465 |
|
|
2018
Q1 | $68K | Buy |
+2,862
| New | +$68K | ﹤0.01% | 3698 |
|